RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ON-DEMAND WEBINARS
This presentation delves into pragmatic approaches for clinical evidence generation and regulatory acceptance. It examines recent FDA draft guidance on integrating RWD/RWE in medical device studies.
Review the latest advancements in wearable digital health technologies (DHTs) and how they are poised to address these challenges and advance treatment options for patients with movement disorders.
Explore key challenges in accessing and preparing analytics-ready clinical data, how FAIR guiding principles can help maximize the value of clinical trial data, and the impact of innovative analytics.
In this free webinar, learn how to update your clinical data strategy that ensures you can scale trials globally while decreasing the overall burden on sites and patients.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1314466105 breast cancer]( "6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies")
6 Key Ways Real-World Data Is Accelerating Breast Cancer TherapiesReal-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.
-
![Virtual doctor patient data]( "Patient Voice Impacts Treatment Experience")
Patient Voice Impacts Treatment ExperienceDownload this guide for five key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.
-
![GettyImages-1300754555-connectivity-communication-network]( "Enhancing Information Dissemination")
Enhancing Information DisseminationBy utilizing advanced digital solutions, Medical Affairs (MA) teams can optimize workflows, reduce their operational burdens, and elevate the quality of communication.
-
![ecoa mobile device patient and doctor]( "3 Benefits Of Centralizing Global Content For eCOA Migration")
3 Benefits Of Centralizing Global Content For eCOA MigrationLearn why now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
![Medable]( "What Happened At ASCO 2024")
What Happened At ASCO 2024Discover our associates' insights on the key developments from ASCO 2024 that are set to shape the future of cancer care and patient outcomes.
-
![teamwork collaboration data analysis-GettyImages-1473508651]( "Webinar Recap: How EDC Can Support Modern Clinical Trials")
Webinar Recap: How EDC Can Support Modern Clinical TrialsGain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.
-
![gettyimages-1374251769-170667a]( "Strong eCOA Provider And Linguistic Validation Expert Partner For Success")
Strong eCOA Provider And Linguistic Validation Expert Partner For SuccessExplore the creation and implementation of the electronic versions of COAs (eCOAs) on a high priority study with a new client.
-
![GettyImages-1429594737 econsent]( "How Partnership Ensured A Successful First Digital Trial")
How Partnership Ensured A Successful First Digital TrialDiscover how this collaborative approach and tailored recommendations led to the successful implementation of an eConsent tool for a kidney cancer study with U.S. Renal Care.
-
![AGI, artificial general intelligence, ai assistant, chatbot-GettyImages-2265775884]( "The Regulatory Governance Gap In Clinical Trial AI")
The Regulatory Governance Gap In Clinical Trial AIRegulators are no longer questioning whether AI belongs in clinical trials; however, they’re demanding a governed infrastructure that makes every AI-driven decision auditable and defensible.
-
![GettyImages-1339597838 clinical data]( "Statistics & Data Management Group Reaches New Heights Of Clinical Trial Efficiency")
Statistics & Data Management Group Reaches New Heights Of Clinical Trial EfficiencyExplore how a contract research organization was able to migrate from paper-based processes to cost-effectively increase efficiency, safeguard data quality, and deliver exceptional service levels to sponsors.
RECENT NEWSLETTERS
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
